• 
  Grégoire Marret, Stéphane Temam, Maud Kamal, Caroline Even, Jean-Pierre Delord, et al.. Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity. Scientific Reports, 2023, 13 (1), pp.22524. ⟨10.1038/s41598-023-49887-4⟩. ⟨hal-04543900⟩
• 
  Thibaud Charrier, Brice Fresneau, Nadia Haddy, Boris Schwartz, Neige Journy, et al.. Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors, a FCCSS Study. RADRES, Oct 2022, Waikoloa, United States. ⟨hal-04488310⟩
• 
  Imène Mansouri, Rodrigue S Allodji, Catherine Hill, Chiraz El‐fayech, François Pein, et al.. The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer. European Journal of Heart Failure, 2018, 21 (4), pp.509 - 518. ⟨10.1002/ejhf.1376⟩. ⟨inserm-04439245⟩
• 
  Grégory Delpon, Alexandre Escande, Timothée Ruef, Julien Darréon, Jimmy Fontaine, et al.. Comparison of Automated Atlas-Based Segmentation Software for Postoperative Prostate Cancer Radiotherapy. Frontiers in Oncology, 2016, 6, ⟨10.3389/fonc.2016.00178⟩. ⟨hal-01683878⟩
• 
  Catherine M. Phelan, Karoline B. Kuchenbaecker, Jonathan Tyrer, Siddhartha Kar, Kate Lawrenson, et al.. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature Genetics, 2017, 49 (5), pp.680-691. ⟨10.1038/ng.3826⟩. ⟨hal-01778538⟩
• 
  Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, Jonathan Dauvé, Christophe Passot, et al.. Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. Journal for Immunotherapy of Cancer, 2023, Journal for ImmunoTherapy of Cancer, 11 (11), pp.e006885. ⟨10.1136/jitc-2023-006885⟩. ⟨hal-04341909⟩
• 
  Jean-Luc Raoul, Marie-Françoise Heymann, Frédéric Dumont, Alain Morel, Hélène Senellart, et al.. Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components. Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.646992⟩. ⟨hal-03623095⟩
• 
  Clémence Basse, Antoine Italiano, Nicolas Penel, Olivier Mir, Claire Chemin, et al.. Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years. International Journal of Cancer, 2019, 145 (8), pp.2135-2143. ⟨10.1002/ijc.32307⟩. ⟨hal-02504786⟩
• 
  Margot Lavy, Vanessa Gauttier, Alison Dumont, Florian Chocteau, Sophie Deshayes, et al.. ChemR23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression. Frontiers in Immunology, 2023, 14, pp.3606 - 3619. ⟨10.3389/fimmu.2023.1196731⟩. ⟨inserm-04198031⟩
• 
  Stéphane Culine, Aude Fléchon, Gwenaelle Gravis, Guilhem Roubaud, Yohann Loriot, et al.. Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study. Clinical Genitourinary Cancer, 2021, 19 (4), pp.e216-e222. ⟨10.1016/j.clgc.2021.02.005⟩. ⟨hal-03631553⟩
• 
  Victoria Corvest, Perrine Marec-Bérard, Cyril Lervat, Hélène D. Pacquement, Maud Toulmonde, et al.. Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France. International Journal of Cancer, 2023, 152 (8), pp.1659-1667. ⟨10.1002/ijc.34326⟩. ⟨hal-04122360⟩
• 
  Renaud Sabatier, Cécile Vicier, Séverine Garnier, Arnaud Guille, Nadine Carbuccia, et al.. Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Molecular Oncology, 2022, 16 (10), pp.2057-2070. ⟨10.1002/1878-0261.13188⟩. ⟨hal-03583253⟩
• 
  Chloé Rousseau, M. Le Thiec, B. Maucherat, M. Frindel, V. Fleury. Place de l’imagerie moléculaire dans la prise en charge du cancer de la prostate. Cancer/Radiothérapie, 2021, 25 (6-7), pp.663-666. ⟨10.1016/j.canrad.2021.07.032⟩. ⟨inserm-03546721⟩
• 
  Anne-Sophie Sertier, Anthony Ferrari, Roxane Pommier, Isabelle Treilleux, Sandrine Boyault, et al.. Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas. Cancer Research Communications, 2023, 3 (5), pp.830-841. ⟨10.1158/2767-9764.CRC-22-0520⟩. ⟨hal-04104571⟩
• 
  Philippe Cassier, Elena Fumagalli, Piotr Rutkowski, Patrick Schöffski, Martine van Glabbeke, et al.. Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era. Clinical Cancer Research, 2012, 18 (16), pp.4458-4464. ⟨10.1158/1078-0432.ccr-11-3025⟩. ⟨hal-03623776⟩
• 
  Marie-Paule Garcia, Henri Der Sarkissian, Erin Mckay, Ludovic Ferrer, Manuel Bardiès, et al.. TestDose : a SPECT image generator for clinical dosimetry studies. SPIE Medical Imaging 2013, SPIE : International Society for Optics and Photonics, Feb 2013, Orlando, United States. pp.1-7, ⟨10.1117/12.2007840⟩. ⟨hal-04084596⟩
• 
  T. Aparicio, O. Bouché, P. L. Etienne, E. Barbier, L. Mineur, et al.. Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial. Digestive and Liver Disease, 2023, 55 (4), pp.541-548. ⟨10.1016/j.dld.2022.08.036⟩. ⟨inserm-03986083⟩
• 
  Ke Zhou, Martine Bellanger, Sophie Le Lann, Marie Robert, Jean-Sebastien Frenel, et al.. The predictive value of patient-reported outcomes on the impact of breast cancer treatment-related quality of life. Frontiers in Oncology, 2022, 12, pp.925534. ⟨10.3389/fonc.2022.925534⟩. ⟨hal-03842272⟩
• 
  Patrick Robelin, Michel Tod, Olivier Colomban, Joel Lachuer, Isabelle Ray-Coquard, et al.. Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study). Gynecologic Oncology, 2020, 159, pp.256 - 263. ⟨10.1016/j.ygyno.2020.07.021⟩. ⟨hal-03491450⟩
• 
  Jean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, Cyrille Touzeau, Hélène Caillon, et al.. Molecular Signature of 18 F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study. Journal of Nuclear Medicine, 2022, 63 (7), pp.1008-1013. ⟨10.2967/jnumed.121.262884⟩. ⟨hal-03807107⟩

92

122